Products & Services

Products: Integrated Medicines Ltd (IML) seeks to impact three opportunities:

(A) the association of an existing diagnostic test with a medicine that is currently in or nearing the market place;

(B) the production of a diagnostic test manufactured exclusively for the purpose of aiding the launch & marketing of a late-stage medicine; and

(C) the development of novel tests, from identification and clinical validation of surrogate biomarkers through to approved diagnostics, in parallel with early-stage medicines development programmes.